Introducing PROTAC Therapy—a Novel Tailored Approach to Lung Cancer Treatment
Introducing PROTAC Therapy—a Novel Tailored Approach to Lung Cancer Treatment

Sahar Abareshi; Yeganeh Yousefi; Niusha Zeynalniya Toosi

Volume 9, Issue 32 , March 2024, , Pages 29-35

https://doi.org/10.22034/pmj.2024.712171

Abstract
  Drug resistance in cancer is a major challenge to properly treating malignancy. Therapies aimed at proteins involved in cancer development may become less effective due to acquired ...  Read More
Analysis of EGFR gene mutations in tissue samples of lung cancer tumors
Analysis of EGFR gene mutations in tissue samples of lung cancer tumors

Blnd Ibrahim Mohammed; Amir Mohammadi; Nafise Poorhasan

Volume 5, Issue 17 , June 2020, , Pages 1-4

https://doi.org/10.22034/pmj.2020.43451

Abstract
  Lung cancer is the leading cause of cancer deaths worldwide. Approximately 25% of nonsmall-cell lung cancers have mutations in the EGFR gene, most of which occur in hotspot regions ...  Read More